生物反馈治疗脑卒中后焦虑症的临床研究

Clinical research into biofeedback therapy to treat post-stroke anxiety

目的观察生物反馈疗法治疗脑卒中后焦虑症的疗效。方法选取60例脑卒中后焦虑症患者,其中治疗组30例,应用生物反馈为主治疗;对照组30例,采用常规治疗,连续治疗2个疗程。疗程结束后采用汉密尔顿焦虑量表(HAMA)、改良巴氏指数评定表(MBI)评定临床疗效。结果 HAMA及MBI评分改善情况两组治疗前后比较差异均有统计学意义(P<0.05),而治疗组改善程度较对照组更显著(P<0.05);治疗组总有效率为93.3%,明显高于对照组的70.0%(P<0.05)。结论生物反馈治疗脑卒中后焦虑症的疗效确切。

Objective To explore the curative effect of biofeedback therapy in treating post-stroke anxiety.Methods 60 patients with post-stroke anxiety were selected and divided into two groups：treatment group and control group, with 30 patients in each group.The 30 patients in the treatment group were treated with biofeedback therapy, while the other 30 patients in the control group were treated with routine therapy for two courses of treatment.After the treatment, HAMA and MBI were adopted to evaluate the therapeutic effects.Results The difference of HAMA and MBI among the two groups before and after the treatment was of statistic significance（P〈0.05）.The improvement degree of the treatment group was obviously higher than that of the control group, with the overall response rate being 93.3 % in the treatment group while 70.0% in the control group（P〈0.05）.Conclusion The study suggests biofeedback is an exactly effective and safe method for treating post-stroke anxiety.